Safety of Herbal Products in Thailand An Analysis of Reports in the Thai Health Product Vigilance Center Database from 2000 to 2008
Background: The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai Vigibase, developed by the Health Product Vigilance Center (HPVC) under the Thai Food and Drug Administration, is the national d...
Saved in:
Published in | Drug safety Vol. 34; no. 4; pp. 339 - 350 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.04.2011
Adis International Wolters Kluwer Health, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0114-5916 1179-1942 |
DOI | 10.2165/11586590-000000000-00000 |
Cover
Abstract | Background:
The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai Vigibase, developed by the Health Product Vigilance Center (HPVC) under the Thai Food and Drug Administration, is the national database that collates reports from health product surveillance systems and programmes. Thai Vigibase can be used to identify signals of adverse events in patients receiving herbal products.
Objectives:
The purpose of the study was to describe the characteristics of reported adverse events in patients receiving herbal products in Thailand.
Methods:
Thai Vigibase data from February 2000 to December 2008 involving adverse events reported in association with herbal products were used. This database includes case reports submitted through the spontaneous reporting system and intensive monitoring programmes. Under the spontaneous reporting system, adverse event reports are collected nationwide via a national network of 22 regional centres covering more than 800 public and private hospitals, and health service centres. An intensive monitoring programme was also conducted to monitor the five single herbal products listed in the Thai National List of Essential Medicines (NLEM), while another intensive monitoring programme was developed to monitor the four single herbal products that were under consideration for inclusion in the NLEM. The database contained patient demographics, adverse events associated with herbal products, and details on seriousness, causality and quality of reports. Descriptive statistics were used for data analyses.
Results:
A total of 593 reports with 1868 adverse events involving 24 different products were made during the study period. The age range of individuals was 1–86 years (mean 47 years). Most case reports were obtained from the intensive monitoring programme. Of the reports, 72% involved females. The herbal products for which adverse events were frequently reported were products containing turmeric (44%), followed by andrographis (10%), veld grape (10%), pennywort (7%), plai (6%), jewel vine (6%), bitter melon (5%) and snake plant (5%). Gastrointestinal problems were the most common adverse effect reported. Serious adverse events included Stevens-Johnson syndrome, anaphylactic shock and exfoliative dermatitis.
Conclusions:
Adverse event reports on herbals products were diverse, with most of them being reported through intensive monitoring programmes. Thai Vigibase is a potentially effective data source for signal detection of adverse events associated with herbal products. |
---|---|
AbstractList | Background: The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai Vigibase, developed by the Health Product Vigilance Center (HPVC) under the Thai Food and Drug Administration, is the national database that collates reports from health product surveillance systems and programmes. Thai Vigibase can be used to identify signals of adverse events in patients receiving herbal products. Objectives: The purpose of the study was to describe the characteristics of reported adverse events in patients receiving herbal products in Thailand. Methods: Thai Vigibase data from February 2000 to December 2008 involving adverse events reported in association with herbal products were used. This database includes case reports submitted through the spontaneous reporting system and intensive monitoring programmes. Under the spontaneous reporting system, adverse event reports are collected nationwide via a national network of 22 regional centres covering more than 800 public and private hospitals, and health service centres. An intensive monitoring programme was also conducted to monitor the five single herbal products listed in the Thai National List of Essential Medicines (NLEM), while another intensive monitoring programme was developed to monitor the four single herbal products that were under consideration for inclusion in the NLEM. The database contained patient demographics, adverse events associated with herbal products, and details on seriousness, causality and quality of reports. Descriptive statistics were used for data analyses. Results: A total of 593 reports with 1868 adverse events involving 24 different products were made during the study period. The age range of individuals was 1-86 years (mean 47 years). Most case reports were obtained from the intensive monitoring programme. Of the reports, 72% involved females. The herbal products for which adverse events were frequently reported were products containing turmeric (44%), followed by andrographis (10%), veld grape (10%), pennywort (7%), plai (6%), jewel vine (6%), bitter melon (5%) and snake plant (5%). Gastrointestinal problems were the most common adverse effect reported. Serious adverse events included Stevens-Johnson syndrome, anaphylactic shock and exfoliative dermatitis. Conclusions: Adverse event reports on herbals products were diverse, with most of them being reported through intensive monitoring programmes. Thai Vigibase is a potentially effective data source for signal detection of adverse events associated with herbal products. Background: The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai Vigibase, developed by the Health Product Vigilance Center (HPVC) under the Thai Food and Drug Administration, is the national database that collates reports from health product surveillance systems and programmes. Thai Vigibase can be used to identify signals of adverse events in patients receiving herbal products. Objectives: The purpose of the study was to describe the characteristics of reported adverse events in patients receiving herbal products in Thailand. Methods: Thai Vigibase data from February 2000 to December 2008 involving adverse events reported in association with herbal products were used. This database includes case reports submitted through the spontaneous reporting system and intensive monitoring programmes. Under the spontaneous reporting system, adverse event reports are collected nationwide via a national network of 22 regional centres covering more than 800 public and private hospitals, and health service centres. An intensive monitoring programme was also conducted to monitor the five single herbal products listed in the Thai National List of Essential Medicines (NLEM), while another intensive monitoring programme was developed to monitor the four single herbal products that were under consideration for inclusion in the NLEM. The database contained patient demographics, adverse events associated with herbal products, and details on seriousness, causality and quality of reports. Descriptive statistics were used for data analyses. Results: A total of 593 reports with 1868 adverse events involving 24 different products were made during the study period. The age range of individuals was 1–86 years (mean 47 years). Most case reports were obtained from the intensive monitoring programme. Of the reports, 72% involved females. The herbal products for which adverse events were frequently reported were products containing turmeric (44%), followed by andrographis (10%), veld grape (10%), pennywort (7%), plai (6%), jewel vine (6%), bitter melon (5%) and snake plant (5%). Gastrointestinal problems were the most common adverse effect reported. Serious adverse events included Stevens-Johnson syndrome, anaphylactic shock and exfoliative dermatitis. Conclusions: Adverse event reports on herbals products were diverse, with most of them being reported through intensive monitoring programmes. Thai Vigibase is a potentially effective data source for signal detection of adverse events associated with herbal products. The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai Vigibase, developed by the Health Product Vigilance Center (HPVC) under the Thai Food and Drug Administration, is the national database that collates reports from health product surveillance systems and programmes. Thai Vigibase can be used to identify signals of adverse events in patients receiving herbal products. The purpose of the study was to describe the characteristics of reported adverse events in patients receiving herbal products in Thailand. Thai Vigibase data from February 2000 to December 2008 involving adverse events reported in association with herbal products were used. This database includes case reports submitted through the spontaneous reporting system and intensive monitoring programmes. Under the spontaneous reporting system, adverse event reports are collected nationwide via a national network of 22 regional centres covering more than 800 public and private hospitals, and health service centres. An intensive monitoring programme was also conducted to monitor the five single herbal products listed in the Thai National List of Essential Medicines (NLEM), while another intensive monitoring programme was developed to monitor the four single herbal products that were under consideration for inclusion in the NLEM. The database contained patient demographics, adverse events associated with herbal products, and details on seriousness, causality and quality of reports. Descriptive statistics were used for data analyses. A total of 593 reports with 1868 adverse events involving 24 different products were made during the study period. The age range of individuals was 1-86 years (mean 47 years). Most case reports were obtained from the intensive monitoring programme. Of the reports, 72% involved females. The herbal products for which adverse events were frequently reported were products containing turmeric (44%), followed by andrographis (10%), veld grape (10%), pennywort (7%), plai (6%), jewel vine (6%), bitter melon (5%) and snake plant (5%). Gastrointestinal problems were the most common adverse effect reported. Serious adverse events included Stevens-Johnson syndrome, anaphylactic shock and exfoliative dermatitis. Adverse event reports on herbals products were diverse, with most of them being reported through intensive monitoring programmes. Thai Vigibase is a potentially effective data source for signal detection of adverse events associated with herbal products. |
Audience | Academic |
Author | Suwankesawong, Wimon Permsuwan, Unchalee Chaiyakunapruk, Nathorn Saokaew, Surasak |
Author_xml | – sequence: 1 givenname: Surasak surname: Saokaew fullname: Saokaew, Surasak organization: School of Pharmacy, University of Phayao – sequence: 2 givenname: Wimon surname: Suwankesawong fullname: Suwankesawong, Wimon organization: Health Product Vigilance Center (HPVC), Food and Drug Administration, Ministry of Public Health – sequence: 3 givenname: Unchalee surname: Permsuwan fullname: Permsuwan, Unchalee organization: Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University – sequence: 4 givenname: Nathorn surname: Chaiyakunapruk fullname: Chaiyakunapruk, Nathorn email: chaiyakunapr@wisc.edu organization: Center of Pharmaceutical Outcomes Research (CPOR), Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, School of Population Health, University of Queensland, School of Pharmacy, University of Wisconsin-Madison |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23985005$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21417506$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkVFLHTEQhUNR6lX7F2ShSJ_WZrKb3eRFEGm1IFSoPodsMrGRvYkmuw_--0b23kqLoMlDhvCdM8OcfbITYkBCKqAnDDr-FYCLjkta0-1Zqg9kBdDLGmTLdsiKArQ1l9Dtkf2c7wsgWCc-kj0GLfScdity_Es7nJ6q6KpLTIMeq-sU7WymXPlQ3fzWftTBHpJdp8eMnzbvAbn9_u3m_LK--nnx4_zsqjatbKa6ExyMbpwQGg3vGQ4Mew2md62z0mLbc8aMEGDk0ErqAI3VA-9pIzUwa5sD8mXxfUjxccY8qbXPBscyA8Y5K1G0BWaikJ8X8k6PqHxwcUraPNPqjHHWNS3nslAnr1DlWlx7U3bqfPn_R3C0GWAe1mjVQ_JrnZ7UdmEFON4AOhs9uqSD8fmFa6TglPLCnS6cSTHnhE4ZP-nJx1Am8KMCqp6TVNsk1d8kl6oYiP8Mtj3eIZWLNBdJuMOk7uOcQgnube0fLQms9Q |
CitedBy_id | crossref_primary_10_1016_j_imr_2020_100469 crossref_primary_10_1007_s40264_013_0055_5 crossref_primary_10_1016_j_sajb_2022_06_042 crossref_primary_10_1111_nep_12531 crossref_primary_10_1002_pds_5190 crossref_primary_10_1016_j_jopr_2013_08_007 crossref_primary_10_1111_jcpt_13106 crossref_primary_10_2196_63808 crossref_primary_10_1007_s11096_022_01533_1 crossref_primary_10_3109_15563650_2012_700402 crossref_primary_10_15406_ppij_2019_07_00257 crossref_primary_10_12688_f1000research_52946_1 crossref_primary_10_3389_fphar_2019_01205 crossref_primary_10_1186_1472_6882_14_515 crossref_primary_10_1371_journal_pone_0141993 crossref_primary_10_4236_health_2020_126044 crossref_primary_10_1097_MOP_0b013e328355a214 crossref_primary_10_3389_fmed_2018_00167 crossref_primary_10_1007_s40264_024_01480_y crossref_primary_10_1016_S1665_2681_19_31464_4 crossref_primary_10_1515_jcim_2013_0016 crossref_primary_10_1007_s11096_011_9597_8 crossref_primary_10_29328_journal_acem_1001026 crossref_primary_10_1016_j_jep_2012_01_051 crossref_primary_10_1007_s00228_015_1898_8 |
Cites_doi | 10.2165/00002018-200225060-00011 10.1046/j.1365-2125.1997.05417.x 10.1345/aph.1D027 10.1345/aph.1G185 10.1002/pds.1445 10.1345/aph.1C186 10.1016/j.amjmed.2003.10.036 10.1345/aph.1D486 10.1016/S1522-8401(00)90026-0 10.1345/aph.1K611 10.1345/aph.1D067 10.1016/j.clinthera.2005.11.004 10.1345/aph.1E460 10.1002/pds.1157 10.1345/aph.1K132 10.1345/aph.1A215 10.1046/j.1365-2125.1999.00060.x 10.2165/00002018-200730070-00006 10.1002/pds.1818 10.2165/00002018-200326120-00001 10.1002/j.1552-4604.1992.tb04635.x 10.1177/009286150804200501 |
ContentType | Journal Article |
Copyright | Adis Data Information BV 2011 2015 INIST-CNRS COPYRIGHT 2011 Wolters Kluwer Health, Inc. |
Copyright_xml | – notice: Adis Data Information BV 2011 – notice: 2015 INIST-CNRS – notice: COPYRIGHT 2011 Wolters Kluwer Health, Inc. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T2 C1K |
DOI | 10.2165/11586590-000000000-00000 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Health and Safety Science Abstracts (Full archive) Environmental Sciences and Pollution Management |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Health & Safety Science Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | MEDLINE Health & Safety Science Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1179-1942 |
EndPage | 350 |
ExternalDocumentID | A252634559 21417506 23985005 10_2165_11586590_000000000_00000 |
Genre | Journal Article |
GeographicLocations | Thailand Asia |
GeographicLocations_xml | – name: Thailand |
GroupedDBID | --- -EM 04C 0R~ 199 29G 2JY 36B 3V. 4.4 406 53G 5GY 5RE 6I2 6PF 7RV 7X7 88E 8FI 8FJ 8R4 8R5 95. AAAUJ AACDK AADNT AAIAL AAIKX AAJKR AAKAS AANZL AARHV AASML AATNV AAWTL AAYOK AAYQN AAYTO AAYZH ABAKF ABDZT ABFTV ABIPD ABJNI ABJOX ABKCH ABKMS ABKTR ABLLE ABMNI ABOCM ABPLI ABTKH ABTMW ABUWG ABWHX ABXPI ACAOD ACCOQ ACCUX ACDTI ACGFO ACGFS ACMJI ACMLO ACOKC ACPIV ACPRK ACREN ACZOJ ADBBV ADFRT ADFZG ADJJI ADQRH ADRFC ADURQ ADYOE ADZCM ADZKW AEBTG AEFQL AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AEVLU AEXYK AEYRQ AFBBN AFKRA AFRAH AFWTZ AFZKB AGAYW AGDGC AGQEE AGQMX AGRTI AHIZS AHMBA AHSBF AIAKS AIGIU AILAN AIZAD AJRNO ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF ASPBG AVWKF AWSVR AXYYD AZFZN A~4 BENPR BGNMA BKEYQ BPHCQ BVXVI BYPQX CAG CCPQU COF CS3 DCUDU DNIVK DPUIP DU5 EBLON EBS EJD EMOBN ESX EX3 F5P FERAY FIGPU FLLZZ FNLPD FSGXE FYUFA HMCUK IAO IHR IMOTQ INH INR ITC IWAJR J-C J5H JZLTJ L7B LGEZI LLZTM LOTEE M1P M4Y NADUK NAPCQ NQJWS NU0 NXXTH O9- OAC OPC OVD P2P PQQKQ PROAC PSQYO Q2X ROL RSV RZALA SISQX SJYHP SNPRN SNX SOHCF SOJ SPKJE SRMVM SSLCW TEORI TSG U9L UAX UG4 UKHRP UTJUX VDBLX VFIZW W48 WAF WOW YFH YQY Z0Y ZGI ZXP ~JE AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AFOHR AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ IQODW PJZUB PPXIY CGR CUY CVF ECM EIF NPM AEIIB PMFND 7T2 C1K PUEGO |
ID | FETCH-LOGICAL-c493t-6851ca3f88aec572eb2e7a1c7f4fd9de47522c881c9b490f1ecdab57039a12dd3 |
ISSN | 0114-5916 |
IngestDate | Sun Sep 28 07:32:10 EDT 2025 Tue Jun 17 21:25:55 EDT 2025 Tue Jun 10 20:45:09 EDT 2025 Thu Jan 02 22:09:30 EST 2025 Mon Jul 21 09:16:22 EDT 2025 Tue Jul 01 00:37:47 EDT 2025 Thu Apr 24 22:58:23 EDT 2025 Fri Feb 21 02:28:14 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Curcuma Longa Community Pharmacist Spontaneous Reporting System Adverse Event Report Herbal Product Vigilance Pharmacognosy Toxicity Plant origin Database Detection Medicinal plant |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c493t-6851ca3f88aec572eb2e7a1c7f4fd9de47522c881c9b490f1ecdab57039a12dd3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 21417506 |
PQID | 888103928 |
PQPubID | 23462 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_888103928 gale_infotracmisc_A252634559 gale_infotracacademiconefile_A252634559 pubmed_primary_21417506 pascalfrancis_primary_23985005 crossref_citationtrail_10_2165_11586590_000000000_00000 crossref_primary_10_2165_11586590_000000000_00000 springer_journals_10_2165_11586590_000000000_00000 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20110400 |
PublicationDateYYYYMMDD | 2011-04-01 |
PublicationDate_xml | – month: 4 year: 2011 text: 20110400 |
PublicationDecade | 2010 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Auckland – name: New Zealand |
PublicationTitle | Drug safety |
PublicationTitleAbbrev | Drug-Safety |
PublicationTitleAlternate | Drug Saf |
PublicationYear | 2011 |
Publisher | Springer International Publishing Adis International Wolters Kluwer Health, Inc |
Publisher_xml | – name: Springer International Publishing – name: Adis International – name: Wolters Kluwer Health, Inc |
References | Bruno, Ellis (CR10) 2005; 39 Meyboom, Lindquist, Egberts (CR23) 2002; 25 CR18 Eland, Belton, van Grootheest (CR25) 1999; 48 CR15 Egberts (CR29) 2007; 30 Lindquist (CR21) 2007; 30 Bianchi, Cantù, Firenzuoli (CR3) 2004; 38 Richard, Jurgens (CR6) 2005; 39 Lindquist (CR20) 2008; 42 (CR14) 2005 Bent, Ko (CR1) 2004; 116 Naranjo, Shear, Lactot (CR19) 1992; 32 Dennehy, Tsourounis, Miller (CR16) 2005; 39 Riewpaiboon (CR13) 2006; 15 Moride, Haramburu, Requejo (CR28) 2003; 43 Jacobosson, Jonsson, Gerden (CR27) 2009; 18 Sleeper, Kennedy (CR7) 2003; 37 Barnes (CR24) 2003; 26 Boullata, McDonnell, Oliva (CR5) 2003; 37 Ahmad, Goetsch, Marks, Strom (CR22) 2005 (CR8) 2004 CR9 Gryzlak, Wallace, Zimmerman (CR26) 2007; 16 Bottenberg, Wall, Harvey (CR4) 2007; 41 (CR30) 2004 Wallace, Gryzlak, Zimmerman (CR17) 2008; 42 Kennedy (CR11) 2005; 27 Burns (CR2) 2000; 1 Martin, Jordan, Vassar (CR12) 2002; 36 Eland (R25-8-20110318) 1999; 48 (R8-8-20110318) 2004 Dennehy (R16-8-20110318) 2005; 39 Naranjo (R19-8-20110318) 1992; 32 Wallace (R17-8-20110318) 2008; 42 Lindquist (R21-8-20110318) 2007; 30 Riewpaiboon (R13-8-20110318) 2006; 15 Lindquist (R20-8-20110318) 2008; 42 Gryzlak (R26-8-20110318) 2007; 16 Jacobosson (R27-8-20110318) 2009; 18 Richard (R6-8-20110318) 2005; 39 Moride (R28-8-20110318) 2003; 43 Barnes (R24-8-20110318) 2003; 26 Meyboom (R23-8-20110318) 2002; 25 Martin (R12-8-20110318) 2002; 36 Sleeper (R7-8-20110318) 2003; 37 Bottenberg (R4-8-20110318) 2007; 41 Boullata (R5-8-20110318) 2003; 37 Egberts (R29-8-20110318) 2007; 30 Bianchi (R3-8-20110318) 2004; 38 Burns (R2-8-20110318) 2000; 1 Bruno (R10-8-20110318) 2005; 39 (R30-8-20110318) 2004 Ahmad (R22-8-20110318) 2005 Kennedy (R11-8-20110318) 2005; 27 Bent (R1-8-20110318) 2004; 116 (R14-8-20110318) 2005 12773073 - Ann Pharmacother. 2003 Jun;37(6):832-5 17726067 - Ann Pharmacother. 2007 Oct;41(10 ):1740-3 1447396 - J Clin Pharmacol. 1992 Oct;32(10):897-904 15187214 - Ann Pharmacother. 2004 Jul-Aug;38(7-8):1222-5 16368456 - Clin Ther. 2005 Nov;27(11):1847-58 16159994 - Ann Pharmacother. 2005 Oct;39(10):1634-9 18397972 - Ann Pharmacother. 2008 May;42(5):653-60 9131950 - Br J Clin Pharmacol. 1997 Feb;43(2):177-81 10583035 - Br J Clin Pharmacol. 1999 Oct;48(4):623-7 17604412 - Drug Saf. 2007;30(7):607-9 12452745 - Ann Pharmacother. 2002 Dec;36(12):1862-9 17613175 - Pharmacoepidemiol Drug Saf. 2007 Sep;16(9):947-57 15741417 - Ann Pharmacother. 2005 Apr;39(4):643-8 16184619 - Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):683-6 15047038 - Am J Med. 2004 Apr 1;116(7):478-85 12503940 - Ann Pharmacother. 2003 Jan;37(1):83-6 19650152 - Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1039-47 12071784 - Drug Saf. 2002;25(6):459-65 12959628 - Drug Saf. 2003;26(12 ):829-51 15741425 - Ann Pharmacother. 2005 Apr;39(4):712-20 |
References_xml | – start-page: 134 year: 2005 end-page: 59 ident: CR22 article-title: Spontaneous reporting in the United States publication-title: Pharmacoepidemiology – volume: 25 start-page: 459 issue: 6 year: 2002 end-page: 65 ident: CR23 article-title: Signal selection and follow-up in pharmacovigilance publication-title: Drug Saf doi: 10.2165/00002018-200225060-00011 – ident: CR18 – volume: 43 start-page: 177 issue: 2 year: 2003 end-page: 81 ident: CR28 article-title: Underreporting of adverse drug reactions in general practice publication-title: Br J Clin Pharmacol doi: 10.1046/j.1365-2125.1997.05417.x – volume: 37 start-page: 832 year: 2003 end-page: 5 ident: CR5 article-title: Anaphylactic reaction to a dietary supplement containing willow bark publication-title: Ann Pharmacother doi: 10.1345/aph.1D027 – volume: 39 start-page: 1634 year: 2005 end-page: 9 ident: CR16 article-title: Evaluation of herbal dietary supplements marketed on the internet for recreational use publication-title: Ann Pharmacother doi: 10.1345/aph.1G185 – volume: 16 start-page: 947 year: 2007 end-page: 57 ident: CR26 article-title: National surveillance of herbal dietary supplement exposure: the poison control center experience publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1445 – volume: 37 start-page: 83 year: 2003 end-page: 6 ident: CR7 article-title: Adverse reaction to a dietary supplement in an elderly patient publication-title: Ann Pharmacother doi: 10.1345/aph.1C186 – volume: 116 start-page: 478 issue: 7 year: 2004 end-page: 85 ident: CR1 article-title: Commonly used herbal medicines in the United States: a review publication-title: Am J Med doi: 10.1016/j.amjmed.2003.10.036 – year: 2004 ident: CR8 publication-title: WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems – volume: 38 start-page: 1222 year: 2004 end-page: 5 ident: CR3 article-title: Rhabdomyolysis caused by , a natural lipid-lowering agent publication-title: Ann Pharmacother doi: 10.1345/aph.1D486 – volume: 1 start-page: 186 issue: 3 year: 2000 end-page: 90 ident: CR2 article-title: Alternative medicine: herbal preparations publication-title: Clin Ped Emerg Med doi: 10.1016/S1522-8401(00)90026-0 – volume: 32 start-page: 897 year: 1992 end-page: 904 ident: CR19 article-title: Advances in the diagnosis of adverse drug reactions publication-title: J Clin Pharmacol – volume: 42 start-page: 653 year: 2008 end-page: 60 ident: CR17 article-title: Application of FDA adverse event report data to the surveillance of dietary botanical supplements publication-title: Ann Pharmacother doi: 10.1345/aph.1K611 – volume: 39 start-page: 712 year: 2005 end-page: 20 ident: CR6 article-title: Effects of natural health products on blood pressure publication-title: Ann Pharmacother doi: 10.1345/aph.1D067 – volume: 27 start-page: 1847 year: 2005 end-page: 58 ident: CR11 article-title: Herb and supplement use in the US adult population publication-title: Clin Ther doi: 10.1016/j.clinthera.2005.11.004 – volume: 39 start-page: 643 year: 2005 end-page: 8 ident: CR10 article-title: Herbal use among US elderly: 2002 national health interview survey publication-title: Ann Pharmacother doi: 10.1345/aph.1E460 – ident: CR15 – volume: 30 start-page: 953 issue: 10 year: 2007 ident: CR21 article-title: Documentation grading of ICSRs and improved data quality management in Vigibase [abstract] publication-title: Drug Saf – ident: CR9 – year: 2005 ident: CR14 publication-title: National policy on traditional medicine and regulation of herbal medicines: report of a WHO global survey – year: 2004 ident: CR30 publication-title: Health products surveillance in community pharmacies – volume: 15 start-page: 683 year: 2006 end-page: 6 ident: CR13 article-title: Increasing herbal product consumption in Thailand publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1157 – volume: 41 start-page: 1740 year: 2007 end-page: 3 ident: CR4 article-title: Oral aloe verainduced hepatitis publication-title: Ann Pharmacother doi: 10.1345/aph.1K132 – volume: 36 start-page: 1862 year: 2002 end-page: 9 ident: CR12 article-title: Herbal and nonherbal alternative medicine use in northwest Ohio publication-title: Ann Pharmacother doi: 10.1345/aph.1A215 – volume: 48 start-page: 623 year: 1999 end-page: 7 ident: CR25 article-title: Attitudinal survey of voluntary reporting of adverse drug reactions publication-title: Br J Clin Pharmacol doi: 10.1046/j.1365-2125.1999.00060.x – volume: 30 start-page: 607 issue: 7 year: 2007 end-page: 9 ident: CR29 article-title: Signal detection: historical background publication-title: Drug Saf doi: 10.2165/00002018-200730070-00006 – volume: 18 start-page: 1039 issue: 11 year: 2009 end-page: 47 ident: CR27 article-title: Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1818 – volume: 42 start-page: 409 year: 2008 end-page: 19 ident: CR20 article-title: VigiBase, the WHO global ICSR database system: basic facts publication-title: Drug Infor J – volume: 26 start-page: 829 issue: 12 year: 2003 end-page: 51 ident: CR24 article-title: Pharmacovigilance of herbal medicines: a UK perspective publication-title: Drug Saf doi: 10.2165/00002018-200326120-00001 – volume: 116 start-page: 478 issue: 7 year: 2004 ident: R1-8-20110318 publication-title: Am J Med doi: 10.1016/j.amjmed.2003.10.036 – year: 2005 ident: R14-8-20110318 – volume: 18 start-page: 1039 issue: 11 year: 2009 ident: R27-8-20110318 publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1818 – year: 2004 ident: R30-8-20110318 – volume: 30 start-page: 607 issue: 7 year: 2007 ident: R29-8-20110318 publication-title: Drug Saf doi: 10.2165/00002018-200730070-00006 – volume: 41 start-page: 1740 year: 2007 ident: R4-8-20110318 publication-title: Ann Pharmacother doi: 10.1345/aph.1K132 – volume: 36 start-page: 1862 year: 2002 ident: R12-8-20110318 publication-title: Ann Pharmacother doi: 10.1345/aph.1A215 – year: 2004 ident: R8-8-20110318 – volume: 27 start-page: 1847 year: 2005 ident: R11-8-20110318 publication-title: Clin Ther doi: 10.1016/j.clinthera.2005.11.004 – volume: 38 start-page: 1222 year: 2004 ident: R3-8-20110318 publication-title: Ann Pharmacother doi: 10.1345/aph.1D486 – volume: 32 start-page: 897 year: 1992 ident: R19-8-20110318 publication-title: J Clin Pharmacol doi: 10.1002/j.1552-4604.1992.tb04635.x – start-page: 134 year: 2005 ident: R22-8-20110318 – volume: 48 start-page: 623 year: 1999 ident: R25-8-20110318 publication-title: Br J Clin Pharmacol doi: 10.1046/j.1365-2125.1999.00060.x – volume: 39 start-page: 643 year: 2005 ident: R10-8-20110318 publication-title: Ann Pharmacother doi: 10.1345/aph.1E460 – volume: 26 start-page: 829 issue: 12 year: 2003 ident: R24-8-20110318 publication-title: Drug Saf doi: 10.2165/00002018-200326120-00001 – volume: 37 start-page: 832 year: 2003 ident: R5-8-20110318 publication-title: Ann Pharmacother doi: 10.1345/aph.1D027 – volume: 39 start-page: 712 year: 2005 ident: R6-8-20110318 publication-title: Ann Pharmacother doi: 10.1345/aph.1D067 – volume: 37 start-page: 83 year: 2003 ident: R7-8-20110318 publication-title: Ann Pharmacother doi: 10.1345/aph.1C186 – volume: 42 start-page: 653 year: 2008 ident: R17-8-20110318 publication-title: Ann Pharmacother doi: 10.1345/aph.1K611 – volume: 1 start-page: 186 issue: 3 year: 2000 ident: R2-8-20110318 publication-title: Clin Ped Emerg Med doi: 10.1016/S1522-8401(00)90026-0 – volume: 42 start-page: 409 year: 2008 ident: R20-8-20110318 publication-title: Drug Infor J doi: 10.1177/009286150804200501 – volume: 16 start-page: 947 year: 2007 ident: R26-8-20110318 publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1445 – volume: 15 start-page: 683 year: 2006 ident: R13-8-20110318 publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.1157 – volume: 25 start-page: 459 issue: 6 year: 2002 ident: R23-8-20110318 publication-title: Drug Saf doi: 10.2165/00002018-200225060-00011 – volume: 43 start-page: 177 issue: 2 year: 2003 ident: R28-8-20110318 publication-title: Br J Clin Pharmacol doi: 10.1046/j.1365-2125.1997.05417.x – volume: 39 start-page: 1634 year: 2005 ident: R16-8-20110318 publication-title: Ann Pharmacother doi: 10.1345/aph.1G185 – volume: 30 start-page: 953 issue: 10 year: 2007 ident: R21-8-20110318 publication-title: Drug Saf – reference: 16184619 - Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):683-6 – reference: 9131950 - Br J Clin Pharmacol. 1997 Feb;43(2):177-81 – reference: 1447396 - J Clin Pharmacol. 1992 Oct;32(10):897-904 – reference: 15741425 - Ann Pharmacother. 2005 Apr;39(4):712-20 – reference: 17613175 - Pharmacoepidemiol Drug Saf. 2007 Sep;16(9):947-57 – reference: 15047038 - Am J Med. 2004 Apr 1;116(7):478-85 – reference: 19650152 - Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1039-47 – reference: 12959628 - Drug Saf. 2003;26(12 ):829-51 – reference: 12071784 - Drug Saf. 2002;25(6):459-65 – reference: 12773073 - Ann Pharmacother. 2003 Jun;37(6):832-5 – reference: 16159994 - Ann Pharmacother. 2005 Oct;39(10):1634-9 – reference: 17604412 - Drug Saf. 2007;30(7):607-9 – reference: 17726067 - Ann Pharmacother. 2007 Oct;41(10 ):1740-3 – reference: 15187214 - Ann Pharmacother. 2004 Jul-Aug;38(7-8):1222-5 – reference: 15741417 - Ann Pharmacother. 2005 Apr;39(4):643-8 – reference: 12503940 - Ann Pharmacother. 2003 Jan;37(1):83-6 – reference: 16368456 - Clin Ther. 2005 Nov;27(11):1847-58 – reference: 10583035 - Br J Clin Pharmacol. 1999 Oct;48(4):623-7 – reference: 12452745 - Ann Pharmacother. 2002 Dec;36(12):1862-9 – reference: 18397972 - Ann Pharmacother. 2008 May;42(5):653-60 |
SSID | ssj0008268 |
Score | 2.102396 |
Snippet | Background:
The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In... The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai... Background: The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In... Background The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In... |
SourceID | proquest gale pubmed pascalfrancis crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 339 |
SubjectTerms | Adolescent Adult Adverse Drug Reaction Reporting Systems - statistics & numerical data Aged Aged, 80 and over Andrographis Biological and medical sciences Child Child, Preschool Clinical trial. Drug monitoring Curcuma longa Data Interpretation, Statistical Databases, Factual - statistics & numerical data Drug Safety and Pharmacovigilance Drug-Related Side Effects and Adverse Reactions - epidemiology Drug-Related Side Effects and Adverse Reactions - etiology Female General pharmacology Health aspects Humans Infant Male Medical sciences Medicine Medicine & Public Health Medicine, Botanic Medicine, Herbal Middle Aged Original Research Article Pharmacognosy. Homeopathy. Health food Pharmacology. Drug treatments Pharmacology/Toxicology Plant Preparations - adverse effects Plant Preparations - standards Retrospective Studies Thailand Vitaceae Young Adult |
Subtitle | An Analysis of Reports in the Thai Health Product Vigilance Center Database from 2000 to 2008 |
Title | Safety of Herbal Products in Thailand |
URI | https://link.springer.com/article/10.2165/11586590-000000000-00000 https://www.ncbi.nlm.nih.gov/pubmed/21417506 https://www.proquest.com/docview/888103928 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe6TkJIE4LyFRiVH2A8sEDjOF-PYwxVSK0q1oq-RY5js6qQVk2jqTzyl3OOnaQdQxvrQ-QmuXz4Lnfn893PCL1WYiRpwmzJfGlTIZnNPCrsJGW-55LUd7mKQw6Gfn9Cv0y9aav1eytrqVgn7_mva-tK7sJV2Ad8VVWy_8HZ-qKwA9rAX9gCh2F7Kx6fMyl0RkUfegc6e6TxW8sc1_EFm5n1OWr389Oq-P4uL6nq0ApbzJnQEzzFiuWsLt05Ly5ZNhc5uzRpu99mP5tJ-xGo9FydoY5MMn4BlqYWklO494bNi4wtV4Ve5Qc8zcUq2w4yqKgp3Q4yVEHGK2HKJlK2HaF0qO1FjsG31loVvnrbieiO2jUxzNl2TKHUoa5GNzLm2NW4tFc1PXF8BYoB_mzoe1FZHK9_utVYtzrnEEY7iiiuSOKaRLf20D4JwP9qo_2PZ8PR19qewwCstOfVi-l8MHWtD_-6_Y6TY0z9wZLl8NlJvV7KdQOavybjSx9n_BA9MIMTfKIl7RFqiayD7g1M-kUHHY000PnmGI-bur38GB_hUQOBvumgAx0NxrrI7TF6oyUVLyTWkoorScWzDFeS-gRNPp-NT_u2WaDD5jRy17YP7jpnrgxDJrgXEJEQETCHB5LKNEoFDcC752Ho8CihUU86gqcsUZhvEXNImrpPUTtbZOI5wl7qsIRQ7qakR3mURoFHfZnIJOAuczmxUFD1aMwNer1aROVHfBNfLeTUlEuN4HILmreKabGSOLgLZ6ZWBZ5VwaXFJ8QjvkthNG6hw50zQTnzncPdHbbXT6BgNz2wgBbClRzEilalPGZiUeRxCP0GHUVCCz3T8tEQOxS8_p5vIVIJTGzUUn7ju724C9FLdL9RC4eovV4V4hV44-uki_aCadA1Hw38G44GfwBjzdGU |
linkProvider | ProQuest |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety+of+Herbal+Products+in+Thailand&rft.jtitle=Drug+safety&rft.au=Saokaew%2C+Surasak&rft.au=Suwankesawong%2C+Wimon&rft.au=Permsuwan%2C+Unchalee&rft.au=Chaiyakunapruk%2C+Nathorn&rft.date=2011-04-01&rft.pub=Springer+International+Publishing&rft.issn=0114-5916&rft.eissn=1179-1942&rft.volume=34&rft.issue=4&rft.spage=339&rft.epage=350&rft_id=info:doi/10.2165%2F11586590-000000000-00000&rft.externalDocID=10_2165_11586590_000000000_00000 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0114-5916&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0114-5916&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0114-5916&client=summon |